The hybrid closed-loop system (a sensor located under the skin that sends wireless readings to an externally worn pump and delivers insulin as needed) could help patients avoid the risks of type 1 diabetes without the worry of finger pricks or injections.
This is not the first device of its kind. Tandemhas been producing similar insulin pumps in the USA since 2019. The NHS hasn’t said which device(s) its program will use, but what’s different is that the country’s publicly funded health care system offers them for free rather than as a special privilege for the wealthy.
hybrid The closed-loop system starts with a sensor placed under the skin that continuously monitors glucose levels at regular intervals.
Artificial organ revolution in medicine, the next stop may be immortality
The sensor sends this data wirelessly to an externally attached pump that provides appropriate insulin dosage. your name
“hybrid” Part of it is that some user input is still required in the self-regulating system, including inputting carbohydrate intake.
State kurumu, giving a very precise figure of 269,095 people living with type 1 diabetes in the UK, highlighted how many people could potentially benefit from this app. The NHS said local branches will begin identifying patients for the scheme from Tuesday.
Colette Marshall, chief executive of Diabetes UK, wrote in the NHS press: “Diabetes is a challenging and relentless condition but these systems make a significant, life-changing difference –
people with diabetes It improves both general health and quality of life. “This is truly a turning point and we will work with the NHS and others to ensure a fair distribution reaches people as quickly as possible.”
Source link: https://www.teknolojioku.com/guncel/tipta-yapay-organ-devrimi-bir-sonraki-durak-olumsuzluk-olabilir-660e53211e4d8d9862051884